INCREASE OLE was the open-label extension of the INCREASE study (NCT02630316), which investigated the safety and efficacy of inhaled treprostinil in patients with pulmonary hypertension due to interstitial lung disease. We caught up with Prof. Jean Elwing (UC Health, Cincinnati, OH, USA) to discuss the methodology, inclusion criteria, and safety and tolerability findings from the […]

BEAT tuberculosis (NCT04062201) investigated treatment with a short course of a delamanid-bedaquiline regimen for rifampicin resistant tuberculosis (RR-TB) in South Africa. It was a pleasure to talk with Dr Francesca Conradie (University of the Witwatersrand, Johannesburg, South Africa) around the aims and design of the BEAT tuberculosis study and the findings from the interim analysis. […]

Point-of-care ultrasound (POCUS) is a potential triage tool for tuberculosis (TB) that could allow non-specialist healthcare workers to guide decision-making in TB management. In this touchRESPIRATORY interview, we speak with Dr. Veronique Suttels (Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland) to discuss the intermediate analysis of the study investigating POCUS in Benin and the potential impact […]

Pulmonary tuberculosis (TB) is a contagious infectious disease caused by Mycobacterium tuberculosis, symptoms can include a cough, chest pain and breathlessness, and in some cases the infection can spread to other organs. In this touchRESPIRATORY interview, we speak with Dr. Veronique Suttels (Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland) to discuss the strengths and limitations of […]

Alpha-1 antitrypsin deficiency (AATD) is a genetic disorder that remains highly undiagnosed. It is estimated that between 1 to 5% of patients with chronic obstructive pulmonary disease (COPD) have AATD; however is often not diagnosed. We caught up with Prof. Charlie Strange (MUSC, Charleston, SC, USA) to discuss what methods are currently available for the […]

Longitudinal studies into the long-term impact of COVID-19 are currently at the forefront of research, touchRESPIRATORY interviewed editorial board member Prof. Margaret Pisani (Yale School of Medicine. New Haven, CT, USA) about what to look out for in 2023 in this area. Disclosures: Margaret Pisani has nothing to disclose in relation to this video interview. Support: Interview and filming […]

CHEST 2022 took place between October 16-19 in Nashville, TN, we interviewed editorial board member Prof. Margaret Pisani (Yale School of Medicine. New Haven, CT, USA) around her personal congress highlights and the networking opportunities which were available on site. Questions What CHEST presentations had the greatest impact this year and what were your personal […]

Once-nightly sodium oxybate (FT218) is currently being investigated in the open label phase 3 study RESTORE (NCT04451668) for the treatment of narcolepsy. We caught up with Prof. John Harsh (University of Colorado Boulder, Boulder, CO, USA) to discuss the aims, design, inclusion criteria and interim findings of the RESTORE study. The abstract ‘LONG-TERM SAFETY OF […]

INSPIRE (LTI-301 clinical trial) was a phase 3 study investigating the long-term safety and tolerability of LIQ861 in patients with pulmonary arterial hypertension (NCT03399604). touchRESPIRATORY were delighted to talk with Dr. Marc Simon (UCSF Health, San Francisco, CA, USA) around the aims, design and eligibility criteria of the LTI-301 clinical trial and the findings from […]